Cantor Fitzgerald Reiterates Overweight Rating on Surgery Partners (SGRY)

Cantor Fitzgerald analyst Sarah James reiterated an Overweight rating and $25.00 price target on Surgery Partners (NASDAQ: SGRY).

The analyst commented, "We view this as the likely bottom for SGRY as we're confident it can correct the discrete pressure it tracked, but caution that it may take until 2H26 for sentiment to reignite. Payor mix & cost pressures arose from shifting competitive dynamics, government payor volume growth & physician retirements. These are all fixable, but given Medicare volumes typically drive 1Q strength, it may take until later in the year for proof of concept."

For an analyst ratings summary and ratings history on Surgery Partners click here. For more ratings news on Surgery Partners click here.

Shares of Surgery Partners closed at $13.92 yesterday.

You May Also Be Interested In

• Molina Healthcare to join S&P MidCap 400, Construction Partners to join S&P SmallCap 600
• Grok launches automated task scheduling with email triggers
• Wipro Ltd. (WIT) PT Lowered to $155 at JPMorgan